Buy now, pay later is a common tool to help shoppers purchase things like consumer electronics and furniture. But can this short-term financing method help people pay for expensive weight-loss drugs?

SEOUL, March 26 (Reuters) - A South Korean appeals court held on Wednesday that main opposition leader Lee Jae-myung was not guilty of violating the election law, reversing a lower court's ruling ...

Only a year ago, as hype was building around the semaglutide drugs Ozempic and Wegovy, conversations revolved around their potential to “end obesity” by helping people drop large amounts of ...

New integration means streamlined ordering and paying experiences for patients, with the same direct shipping and the best self-pay price on single-dose Zepbound vials NEW YORK CITY, March 24, 2025 ...

LONDON (Reuters) -Novo Nordisk shares have fallen 25% so far in March and are on track for their biggest monthly drop since July 2002, as investor worries intensify that the obesity drug market ...

LONDON, March 27 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab shares have fallen 25% so far in March and are on track for their biggest monthly drop since July 2002, as investor worries ...

NEW YORK CITY, March 24, 2025 (GLOBE NEWSWIRE) -- Sesame, the company that offers Americans quality, convenient health care at half the typical price, today announced a technical integration with ...

Well before market open that morning, Morgan Stanley's Thibault Boutherin knocked his Novo Nordisk price target down to 600 Danish kroner ($86.67) per share; previously, this number was 700 kroner ...

Novo Nordisk has quickly expanded its discounted Wegovy program, now offering all eligible cash-paying customers its popular weight-loss med at $499 per month. Novo had only launched the cheaper ...

With a FDA deadline set for March 26 to stop compounding versions of Zepbound, followed by restrictions on compounded Ozempic and Wegovy set for later this spring, the agency is meeting resistance ...